Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

IRAK inhibitor 1

Copy Product Info
🥰Excellent
Catalog No. T5094Cas No. 1042224-63-4

IRAK inhibitor 1 is an effective IRAK-4 inhibitor (IC50: 216 nM), is poorly active against JNK-1 (IC50: 3.801 μM) and JNK-2 (IC50>10 μM).

IRAK inhibitor 1

IRAK inhibitor 1

Copy Product Info
🥰Excellent
Purity: 99.99%
Catalog No. T5094Cas No. 1042224-63-4
IRAK inhibitor 1 is an effective IRAK-4 inhibitor (IC50: 216 nM), is poorly active against JNK-1 (IC50: 3.801 μM) and JNK-2 (IC50>10 μM).
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$87In StockIn Stock
2 mg$127In StockIn Stock
5 mg$213In StockIn Stock
10 mg$297In StockIn Stock
25 mg$497In StockIn Stock
50 mg$723In StockIn Stock
100 mg$987In StockIn Stock
1 mL x 10 mM (in DMSO)$137In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.99%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

IRAK inhibitor 1 AI Summary
IRAK inhibitor 1 inhibits IRAK4 with an IC50 value of 35.0 nM and shows partial inhibition of JNK1 (39.0% at 10 µM) and JNK2 (15.0% at 10 µM). It exhibits 14.19% inhibition of SARS-CoV-2 3CL-Pro protease at a concentration of 20 µM, indicating potential antiviral activity against the SARS-CoV-2 virus. Additionally, it shows minor antiviral activity against SARS-CoV-2 in VERO-6 cells at a 10 µM concentration after 48 hours of exposure, but with an inhibition rate of -0.21%. Moreover, IRAK inhibitor 1 has moderate cytotoxicity against human HepG2 cells, with an IC50 value of 4500.0 nM as determined by the CellTiter-Glo luminescent cell viability assay..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
IRAK inhibitor 1 is an effective IRAK-4 inhibitor (IC50: 216 nM), is poorly active against JNK-1 (IC50: 3.801 μM) and JNK-2 (IC50>10 μM).
Targets&IC50
JNK1:3.801 μM, IRAK4:216 nM
Chemical Properties
Molecular Weight293.37
FormulaC17H19N5
Cas No.1042224-63-4
SmilesC1CC(CCN1)Nc1cccc(n1)-c1cnc2ccccn12
Relative Density.1.32 g/cm3
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 10 mg/mL (34.09 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 1 mg/mL (3.41 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.4087 mL17.0433 mL34.0866 mL170.4332 mL
5 mM0.6817 mL3.4087 mL6.8173 mL34.0866 mL
10 mM0.3409 mL1.7043 mL3.4087 mL17.0433 mL
20 mM0.1704 mL0.8522 mL1.7043 mL8.5217 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy IRAK inhibitor 1 | purchase IRAK inhibitor 1 | IRAK inhibitor 1 cost | order IRAK inhibitor 1 | IRAK inhibitor 1 chemical structure | IRAK inhibitor 1 formula | IRAK inhibitor 1 molecular weight